Race against time: new combo therapy aims to save brain function after severe stroke
NCT ID NCT05701956
Summary
This study tested whether adding a clot-busting drug (tenecteplase) to a standard mechanical clot removal procedure (thrombectomy) leads to better recovery for people having a severe stroke caused by a blockage in a critical brain artery. It involved 330 adults who could receive treatment between 4.5 and 24 hours after their stroke began. The main goal was to see if the combined treatment helped more people regain independence in daily activities 90 days later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASILAR ARTERY OCCLUSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, 230001, China
Conditions
Explore the condition pages connected to this study.